Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05251090
What this trial is testing

Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection

Who this might be right for
Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 13
Testing effectiveness (Phase 2)Study completedNCT02507388
What this trial is testing

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Alcon Research 51
Large-scale testing (Phase 3)Study completedNCT02093897
What this trial is testing

Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A

Who this might be right for
Congenital Hemophilia A
CSL Behring 84
Early research (Phase 1)Study completedNCT04798313
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults

Who this might be right for
Osteoporosis, Postmenopausal
Mabwell (Shanghai) Bioscience Co., Ltd. 120
Early research (Phase 1)Study completedNCT02471859
What this trial is testing

A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants

Who this might be right for
Healthy Volunteer
Genentech, Inc. 8
Early research (Phase 1)Ended earlyNCT01078376
What this trial is testing

A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults

Who this might be right for
Hypertension
Takeda 29
Testing effectiveness (Phase 2)WithdrawnNCT00390091
What this trial is testing

Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
La Jolla Pharmaceutical Company
Early research (Phase 1)Study completedNCT00854113
What this trial is testing

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

Who this might be right for
Safety and Tolerability of EGT0001474 in Healthy Volunteers
Theracos 78
Early research (Phase 1)Not Yet RecruitingNCT07567859
What this trial is testing

HS-10587 in Patients With Advanced Solid Tumors

Who this might be right for
MTAP Deletion
Jiangsu Hansoh Pharmaceutical Co., Ltd. 362
Testing effectiveness (Phase 2)Study completedNCT03965858
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

Who this might be right for
Major Depressive Disorder
Celon Pharma SA 88
Early research (Phase 1)Study completedNCT04798326
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults

Who this might be right for
Bone Tumor
Mabwell (Shanghai) Bioscience Co., Ltd. 120
Early research (Phase 1)UnknownNCT06578676
What this trial is testing

To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults

Who this might be right for
Type 2 DiabetesDyslipidemias
Hyundai Pharm 56
Testing effectiveness (Phase 2)Ended earlyNCT05737212
What this trial is testing

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Who this might be right for
Recurrent High-grade GliomaRecurrent GlioblastomaRecurrent Anaplastic Astrocytoma+1 more
Dawonmedax Co., Ltd. 7
Early research (Phase 1)Study completedNCT02323334
What this trial is testing

LY3202626 in Healthy Participants and Participants With Alzheimer's Disease

Who this might be right for
Healthy VolunteersAlzheimer Disease
Eli Lilly and Company 94
Early research (Phase 1)UnknownNCT05278832
What this trial is testing

QLS31905 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 104
Early research (Phase 1)Study completedNCT02644278
What this trial is testing

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 15
Early research (Phase 1)Study completedNCT03364985
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 123
Early research (Phase 1)Study completedNCT00618124
What this trial is testing

Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

Who this might be right for
Solid TumorsBreast CancerNeoplasms
Pfizer 77
Early research (Phase 1)Study completedNCT01776047
What this trial is testing

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Who this might be right for
Healthy Male Volunteer
Dong-A Pharmaceutical Co., Ltd. 51
Early research (Phase 1)UnknownNCT05650385
What this trial is testing

B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors

Who this might be right for
Neoplasms Malignant
Tasly Biopharmaceuticals Co., Ltd. 68
Next Page